Articles tagged with: AIDSmap

New South Wales puts 9000 people on PrEP, achieves a one-third decline in new HIV infections

published: March, 20, 2018 Written by // Guest Authors - Revolving Door Categories // Activism, Social Media, As Prevention , Gay Men, Current Affairs, Treatment Guidelines -including when to start, Health, International , Revolving Door, Treatment, Media, Guest Authors

Successful appeal to state government got ‘cap’ lifted on PrEP demo trial. From AIDSmap, Gus Cairns reports.

New South Wales puts 9000 people on PrEP, achieves a one-third decline in new HIV infections

The state of New South Wales in Australia has seen a fall of one-third in diagnoses of recent HIV infection since it started its pre-exposure prophylaxis (PrEP) implementation project, EPIC-NSW (Expanded PrEP Implementation in the Community), the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) heard last week. Andrew Grulich of the Kirby Institute of the University of New South Wales told the conference that only two people who entered EPIC-NSW had been diagnosed wi

How much "PrEP-resistant" HIV is out there?

published: March, 12, 2018 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, As Prevention , Gay Men, Conferences, Current Affairs, Treatment Guidelines -including when to start, Health, Research, International , Revolving Door, Treatment, Media, Guest Authors

From AIDSmap, Gus Cairns reports from the recent 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018).

How much

A study presented at the recent 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) aims to quantify how many people with HIV there might be in the community who both have a detectable HIV viral load and also have significant resistance to tenofovir and emtricitabine, the two drugs currently used in pre-exposure prophylaxis (PrEP). The researchers, from the University of Washington in Seattle, found that in King County, which contains Seattle, no more than 0.3% of the l

New HIV infections halved after scale-up of HIV treatment, circumcision, in Uganda's hardest-hit district

published: March, 08, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, African, Caribbean and Black, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Health, International , Revolving Door, Treatment, Media, Guest Authors

From AIDSmap, Michael Carter and Keith Alcorn report on the Rakai Community Cohort Study.

New HIV infections halved after scale-up of HIV treatment, circumcision, in Uganda's hardest-hit district

The rate of new HIV infections has halved since 2011 in a Ugandan community following large increases in male circumcision, antiretroviral treatment and viral suppression, Frank Kagaayi of the Rakai Health Sciences Program told the Conference on Retroviruses and Opportunistic Infections in Boston on Tuesday. Dr Kagaayi was presenting results from the Rakai Community Cohort Study, focusing on repeat surveys of one fishing village with a very high prevalence and incidence of HIV infection. The

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

published: March, 07, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, International AIDS Conference , As Prevention , Conferences, Current Affairs, Treatment Guidelines -including when to start, Research, Health, International , Revolving Door, Treatment, Media, Guest Authors

Five of eleven treated animals still remained virally suppressed at six months. From AIDSmap, Liz Highleyman reports.

Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys

Dan Barouch presenting at CROI 2018. Photo by Liz Highleyman Treatment with a broadly neutralising antibody plus an immune-stimulating drug led to long-term viral remission after interrupting antiretroviral therapy in a monkey study, according to data presented at the 25th Conference on Retroviruses and Opportunistic Infections (CROI 2018) this week in Boston. Monkeys that received both the antibody, known as PGT121, and the TLR7 agonist GS-9620 maintained an undetectable viral load withou

US studies underline importance of primary care physicians for people with HIV

published: March, 05, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, General Health, Research, Health, International , Revolving Door, Media, Guest Authors

From AIDSmap, Keith Alcorn reports on two studies assessing the influence of provider type on outcomes of chronic co-morbidities in HIV.

US studies underline importance of primary care physicians for people with HIV

People with HIV who have other medical conditions such as high blood pressure or high lipids appear to do better if they have a primary care physician as well as an HIV physician, according to a study of people receiving care through UCLA Center for Clinical AIDS Research and Education, researchers report in The Journal of Infectious Diseases. A second study, looking at chronic medical conditions, or co-morbidities, in a large sample of people with HIV in the United States found that high b

Chronic depression leads to poorer engagement with key stages of HIV care continuum, say US researchers

published: February, 28, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, Mental Health, Research, Health, International , Revolving Door, Media, Guest Authors

From AIDSmap, Michael Carter reports on a study designed to examine the association between chronic depression and clinical outcomes.

Chronic depression leads to poorer engagement with key stages of HIV care continuum, say US researchers

Increased time spent living with depression is associated with poorer engagement with the HIV care continuum, investigators from the United States report in JAMA Psychiatry. Chronic depression was associated with missing appointments, a detectable viral load and an increased mortality risk. “We found that a greater proportion of time spent with depression increased the risk of missed primary care appointments and lack of viral suppression in a dose-response manner,” comment the autho

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

published: February, 26, 2018 Written by // Guest Authors - Revolving Door Categories // International AIDS Conference , Social Media, As Prevention , Conferences, Current Affairs, Treatment Guidelines -including when to start, Health, International , Revolving Door, Treatment, Media, Guest Authors, Opinion Pieces

From AIDSmap, Gus Cairns reports on the PrEP In Europe Summit 2018

HIV prevention: It’s time to stop accepting the status quo, PrEP Summit concludes

The biggest barrier to HIV pre-exposure prophylaxis (PrEP) becoming more available and more widely used is not cost so much as widespread acceptance of the status quo in HIV prevention, the first-ever European PrEP Summit, held in Amsterdam ten days ago, heard. Ignorance – among politicians, among healthcare workers, and among potential users of PrEP – was the main reason Europe lags far behind the USA in PrEP provision, despite there being a possibly more favourable climate in terms of p

High prevalence of hypertension among HIV-positive patients in the US with 'missed opportunities' for its diagnosis and control

published: February, 14, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, General Health, Mental Health, Research, Health, International , Revolving Door, Media, Guest Authors

“We found that about 1 in 8 patients has undiagnosed and untreated hypertension,” write the researchers. From AIDSmap, Michael Carter reports.

High prevalence of hypertension among HIV-positive patients in the US with 'missed opportunities' for its diagnosis and control

  There is a high prevalence of hypertension among HIV-positive patients in the United States and many of these individuals are not receiving hypertensive therapy, investigators report in Clinical Infectious Diseases. Overall, 42% of patients were classified as hypertensive and 13% of these patients were undiagnosed with a further 26% with uncontrolled high blood pressure despite therapy. “We found that about 1 in 8 patients has undiagnosed and untreated hypertension,” write the researc

Generic drugs for HIV treatment may save money, but barriers to prescription make savings elusive

published: February, 08, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Current Affairs, Treatment Guidelines -including when to start, Research, Health, International , Revolving Door, Treatment, Media, Guest Authors

Scepticism among healthcare providers, patients and pharmacists about the safety and efficacy of generic medications is an important barrier. From AIDSmap, Keith Alcorn reports.

Generic drugs for HIV treatment may save money, but barriers to prescription make savings elusive

The potential savings from prescribing generic antiretrovirals predicted by economic models may be overstated and numerous barriers need to be overcome to bring down the cost of HIV treatment in higher-income countries, according to the findings of several recently-published analyses. Switching to cheaper generic versions of some antiretrovirals has been proposed as a means of freeing up money to treat more people with HIV in the United States and other higher-income countries where generics

Women with HIV less likely to receive recommended treatments for gynaecologic cancers

published: January, 29, 2018 Written by // Guest Authors - Revolving Door Categories // Social Media, As Prevention , Treatment Guidelines -including when to start, Women, Health, International , Revolving Door, Treatment, Living with HIV, Media, Guest Authors

Toxicity and patient factors were the main reasons why women did not receive treatment recommended in guidelines.From AIDSmap, Michael Carter reports.

Women with HIV less likely to receive recommended treatments for gynaecologic cancers

The majority of HIV-positive women diagnosed with gynaecological cancer do not receive treatment recommended by cancer guidelines, according to research conducted in the United States and published in AIDS. Women whose care did not match guideline standards had poorer survival compared to women who received the recommended care. Toxicity and patient factors were the main reasons why women did not receive treatment recommended in guidelines. “To our knowledge, there is no case series de

[12 3 4 5  >>